Pages that link to "Q58593899"
Jump to navigation
Jump to search
The following pages link to Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer (Q58593899):
Displaying 8 items.
- Maternal Embryonic Leucine Zipper Kinase Promotes Tumor Growth and Metastasis via Stimulating FOXM1 Signaling in Esophageal Squamous Cell Carcinoma (Q89668182) (← links)
- Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma (Q91329661) (← links)
- Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway (Q91846035) (← links)
- Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma (Q92153843) (← links)
- Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling (Q92216924) (← links)
- MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway (Q92501934) (← links)
- Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis (Q98778911) (← links)
- microRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer (Q101241270) (← links)